Blog | HemaCare

Dendritic Cells: Rabble-Rousers after Stem Cell Transplantation

Apr 16, 2014 1:00:50 PM / by Daisy posted in GVHD, proteasome inhibitors, research, T Cells


Stem cell transplantation is often the only option for patients who have certain blood cancers. Unfortunately, this last resort can sometimes bring more harm than good. Graft versus host disease (GVHD), is a common complication that affects 50% of transplant patients. GVHD is not an issue if the patient's own stem cells are transplanted back. However, GVHD can become an issue, sometimes fatal, when stem cells from another donor are used.

Read More

New Drugs for Multiple Myeloma - A Disease of PBMC

Apr 9, 2014 1:00:46 PM / by Maria posted in Innovation, multiple myeloma, proteasome inhibitors


Proteasomes - the target in cancerous PBMC's for proteasome inhibitor drugs. Image credits: Wikimedia Commons
Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts